Veterinary News and Research

RSS

New study reveals transmission of NDM-bacteria between dogs and humans

In 2015, a New Delhi -metallo-beta-lactamase Escherichia coli bacteria was discovered in two Finnish dogs.An article recently published in the journal Eurosurveillance reveals that the dogs' owner did also carry the bacterium.

9 Jul 2018

Researchers discover critical link in mapping recurrent mutations of melanoma

A critical link in mapping recurrent mutations of melanoma -- the most serious form of skin cancer in humans -- has been discovered by researchers at Washington State University School of Molecular Biosciences, in collaboration with researchers at Georgia State University.

6 Jul 2018

FDA grants approval for new device to treat breathing difficulty caused by severe emphysema

The U.S. Food and Drug Administration today approved a new device, the Zephyr Endobronchial Valve (Zephyr Valve), intended to treat breathing difficulty associated with severe emphysema.

29 Jun 2018

Researcher wins $2 million NIH grant to study immunological memory

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a $2 million, five-year grant to Ken Oestreich, an assistant professor at the Virginia Tech Carilion Research Institute, to study immunological memory.

27 Jun 2018

Researchers develop new approach for studying Cryptosporidium in healthy human tissues

Washington State University researchers have developed a new approach for studying Cryptosporidium, a waterborne gastrointestinal parasite now recognized as one of the leading causes of potentially life-threatening diarrheal disease in young children worldwide.

26 Jun 2018

Experts witness action of influenza infection in the lungs of living mice

In the 1966 novel, Fantastic Voyage, written by biochemist and author Isaac Asimov, a crew of people become miniaturized in order to travel through the body of a scientist and save him from a blood clot in his brain.

26 Jun 2018

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.

25 Jun 2018

FDA grants marketing authorization for use of two catheter-based devices in hemodialysis patients

Today, the U.S. Food and Drug Administration permitted marketing of two catheter-based devices designed to create a connection to veins and arteries in patients with chronic kidney disease who need hemodialysis.

22 Jun 2018

New guide published to help battle fatal disease caused by kissing bugs

A guide to help battle a potentially fatal disease transferred by a blood-sucking insect called the kissing bug has been published by a task force led by The University of Texas Health Science Center at Houston.

22 Jun 2018

FDA expands approval of novel diabetes management device to include younger pediatric patients

The U.S. Food and Drug Administration today expanded the approval of the MiniMed 670G hybrid closed looped system, a diabetes management device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses with little or no input from the user, to include individuals aged 7 to 13 with type 1 diabetes.

21 Jun 2018

FDA approves Eversense CGM system for use in adults with diabetes

The U.S. Food and Drug Administration today approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people 18 years of age and older with diabetes.

21 Jun 2018

Researchers study broader effects of neonics on wildlife

Health impacts of neonicotinoids may go well beyond bees, according to a new University of Guelph study.

21 Jun 2018

Rhesus macaque model could be useful to test therapies for congenital Zika virus syndrome

Rhesus macaque monkeys infected in utero with Zika virus develop similar brain pathology to human infants, according to a report by researchers at the California National Primate Research Center and School of Veterinary Medicine at the University of California, Davis, published June 20 in Nature Communications.

21 Jun 2018

Fetal immune cells are fast-acting first responders to microbes in adulthood

Cornell University researchers have discovered there is a division of labor among immune cells that fight invading pathogens in the body.

20 Jun 2018

Researchers propose new strategy to combat micro-pollutants in water

Pharmaceutical residues from domestic dwellings, hospitals and agriculture are contaminating our water.

19 Jun 2018

Novel compound as effective as FDA-approved antibiotics for treating deadly infections

Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.

18 Jun 2018

Study shows how using service dogs may provide physiological benefits to veterans with PTSD

A new study shows how veterans with PTSD may benefit physiologically from using service dogs.

12 Jun 2018

FDA files complaint against company marketing unapproved hand sanitizers

The U.S. Food and Drug Administration today filed a complaint against Innovative BioDefense, Inc. of Lake Forest, California, and Colette Cozean, the company's president and chief executive officer, to prohibit them from selling Zylast topical antiseptics with claims that they are effective against infection by pathogens such as norovirus, rotavirus, flu virus, Methicillin-Resistant Staphylococcus Aureus, and Ebola.

7 Jun 2018

Regeneron collaborates with Zoetis to research antibody therapies for animals

Regeneron Pharmaceuticals, Inc. and Zoetis Inc. today announced a five-year collaboration to research the use of Regeneron's monoclonal antibody therapeutics in animals and discover new veterinary treatments.

6 Jun 2018

FDA warns nine online networks to stop illegal marketing of unapproved opioids

The U.S. Food and Drug Administration today announced that it has warned nine online networks, operating a total of 53 websites, that they must stop illegally marketing potentially dangerous, unapproved and misbranded versions of opioid medications, including tramadol and oxycodone.

6 Jun 2018

Veterinary News and Research

New study reveals transmission of NDM-bacteria between dogs and humans

Researchers discover critical link in mapping recurrent mutations of melanoma

FDA grants approval for new device to treat breathing difficulty caused by severe emphysema

Researcher wins $2 million NIH grant to study immunological memory

Researchers develop new approach for studying Cryptosporidium in healthy human tissues

Experts witness action of influenza infection in the lungs of living mice

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

FDA grants marketing authorization for use of two catheter-based devices in hemodialysis patients

New guide published to help battle fatal disease caused by kissing bugs

FDA expands approval of novel diabetes management device to include younger pediatric patients

FDA approves Eversense CGM system for use in adults with diabetes

Researchers study broader effects of neonics on wildlife

Rhesus macaque model could be useful to test therapies for congenital Zika virus syndrome

Fetal immune cells are fast-acting first responders to microbes in adulthood

Researchers propose new strategy to combat micro-pollutants in water

Novel compound as effective as FDA-approved antibiotics for treating deadly infections

Study shows how using service dogs may provide physiological benefits to veterans with PTSD

FDA files complaint against company marketing unapproved hand sanitizers

Regeneron collaborates with Zoetis to research antibody therapies for animals

FDA warns nine online networks to stop illegal marketing of unapproved opioids

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News